Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + hydromorphone for postoperative analgesia in elderly laparoscopic cholecystectomy
ChiCTR2600120361Phase 4Recruiting
- Sponsor
- Hengshui People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain, major depressive episode (MDE), postoperative delirium (POD) and 1 more (2 arms), sponsored by Hengshui People's Hospital. Primary endpoint: Depression level. Started Mar 2026; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painmajor depressive episode (MDE)postoperative delirium (POD)confusion
Beyond the preview
Go deeper on ChiCTR2600120361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120361.